Interview Olivier Soula – Bourse et Valeurs – July 2025 (FR)
25 Jul 2025 ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T2D Icon check
23 Jul 2025 ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update Icon check
16 Jul 2025 ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets Icon check
11 Jul 2025 Number of Shares and Voting Rights of ADOCIA as of June 30th, 2025 Icon check
24 Jun 2025 ADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell® from Human Islets to Stem Cell-Derived Islets Icon check
16 Jun 2025 AdoShell®, a non-fibrotic encapsulation system for human islet transplantation without immunosuppression, Oral Presentation, Dr Anne-Lise Gaffuri, 20th World Congress of the international pancreas and islet transplant association (IPITA 2025) Icon check
General Shareholders Meeting – June 11, 2025 (FR)
12 Jun 2025 Number of Shares and Voting Rights of ADOCIA as of May 31st, 2025 Icon check
12 Jun 2025 Adoshell®: a permselective and non-fibrotic scaffold for human islet transplantation, Poster, Dr Clément Cocita, European islet study group 2025, Malmö, Sweden Icon check
22 May 2025 ADOCIA Confirms its Eligibility for the PEA PME Scheme Icon check
21 May 2025 ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 11th, 2025 in Paris Icon check
15 May 2025 Number of Shares and Voting Rights of ADOCIA as of April 30th, 2025 Icon check
14 May 2025 ADOCIA Reports First Quarter 2025 Financial Results and Provides a Business Update Icon check
30 Apr 2025 ADOCIA Announces the Release of its Universal Registration Document for the Year 2024 Icon check
28 Apr 2025 ADOCIA to Present New Data on AdoShell® at Upcoming Scientific Conferences – Showcasing Potential Curative Treatment for Type 1 Diabetes Icon check
17 Apr 2025 ADOCIA Announces Full Year 2024 Financial Results and Provides a Corporate and Financial Update Icon check
11 Apr 2025 Number of Shares and Voting Rights of ADOCIA as of March 31st, 2025 Icon check
02 Apr 2025 Développement d’AdoGel®, un hydrogel injectable permettant une libération prolongée de semaglutide sur un mois, Short Oral Presentation, Dr Audrey Maréchal, Congrès annuel de la SFD 2025 Icon check
02 Apr 2025 AdoShell®, un nouveau biomatériau pour la transplantation d’ilots, Short Oral Presentation, Camille Gautier, Congrès annuel de la SFD 2025 Icon check
20 Mar 2025 AdoShell®, a non-fibrotic immunoprotective hydrogel shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Anne-Lise Gaffuri, 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), Amsterdam, Netherlands Icon check
14 Mar 2025 Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025 Icon check
28 Feb 2025 ADOCIA Announces the Settlement-Delivery of its €9.7 Million Private Placement Icon check
26 Feb 2025 ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026 Icon check
25 Feb 2025 ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update Icon check
14 Feb 2025 Number of Shares and Voting Rights of ADOCIA as of January 31st, 2025 Icon check
28 Jan 2025 AdoShell®, a non-fibrotic immunoprotective hydrogel containing human islets shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Ouardane Jouannot, 14th EPITA Symposium, Pisa, Italy Icon check
22 Jan 2025 ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets Icon check
17 Jan 2025 Number of Shares and Voting Rights of ADOCIA as of December 31st, 2024 Icon check
23 Dec 2024 ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025 Icon check
19 Dec 2024 ADOCIA Announces its Financial Calendar for 2025 Icon check
12 Dec 2024 ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone® Lispro, Milestone Associated with a $10 Million Payment Icon check
04 Dec 2024 Number of Shares and Voting Rights of ADOCIA as of November 30th, 2024 Icon check
08 Nov 2024 Number of Shares and Voting Rights of ADOCIA as of October 31st, 2024 Icon check
Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse 2024 (FR)
30 Oct 2024 ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update Icon check
15 Oct 2024 ADOCIA announces patenting stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its BioChaperone® platform Icon check
08 Oct 2024 Number of Shares and Voting Rights of ADOCIA as of September 30th, 2024 Icon check
23 Sep 2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Financial Officer Icon check
20 Sep 2024 Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024 Icon check
19 Sep 2024 ADOCIA Announces First Half 2024 Financial Results and Provides a Business Update Icon check
13 Sep 2024 Development of a once-a-month formulation of Semaglutide from an innovative injectable and biodegradable hydrogel, Short Oral Presentation, Dr Claire Mégret, 60th annual meeting, EASD 2024, Madrid, Spain Icon check
10 Sep 2024 ADO12, a non-fibrotic immunoprotective hydrogel containing human islets shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Anne-Lise Gaffuri, 60th annual meeting, EASD 2024, Madrid, Spain Icon check
30 Aug 2024 Number of Shares and Voting Rights of ADOCIA as of July 31st, 2024 Icon check
29 Aug 2024 ADOCIA to Deliver Oral Presentations on AdoShell® and AdoGel® at EASD Annual Meeting Icon check
24 Jul 2024 ADOCIA Reports Second Quarter 2024 Financial Results and Provides a Business Update Icon check
19 Jul 2024 ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
11 Jul 2024 Number of Shares and Voting Rights of ADOCIA as of June 30th, 2024 Icon check
Web Conference – BioChaperone Combo – July 2024 (FR)
Join our mailing list. Subscribe